Zymeworks Inc. (ZYME)
$0.00+$0.00 (+0.00%) TodayExtended Hours
Latest ZYME Insider Trades
Mark Hollywood - Officer
Mark Hollywood - Officer
Jeffrey T. L. Smith - OfficerJeffrey T. L. Smith - OfficerZymeworks Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of next-generation multifunctional biotherapeutics. Its suite of therapeutic platforms and its fully integrated drug development engine enables precise engineering of differentiated therapeutic product candidates. Its clinical candidate, zanidatamab, is a novel HER2-targeted bispecific antibody currently being evaluated in multiple Phase 1, Phase 2, and pivotal clinical trials globally as a targeted treatment option for patients with solid tumors that express HER2. It is also advancing a deep preclinical pipeline in oncology and other therapeutic areas.
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Grant or award | 1 | 939 |
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
33 Form 4 filings on record, the earliest from Dec 12, 2024, newest first. Filing history page 2 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
 Troy Cox | Grant or award | Stock Option (Right to Buy) | 31,000 | $0.00 | - | |
| Carlos Campoy | Grant or award | Stock Option (Right to Buy) | 31,000 | $0.00 | - | |
| Neil Gallagher | Grant or award | Stock Option (Right to Buy) | 31,000 | $0.00 | - |
This is as far as the anonymous view goes. Create a free account for all 33 ZYME filings on record.
Zymeworks Inc. (ZYME) had 1 insider filing in the last 90 days, with the most recent on 2026-07-06. The full record for ZYME runs to 33 Form 4 filings, the earliest from 2024-12-12. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
No insider purchases of ZYME were filed in the last 90 days. 4 purchases are on record for this company.
No insider sales of ZYME were filed in the last 90 days. 10 sales are on record for this company.
This page tracks ZYME Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
Create a free InsiderAlpha account and press Watch on this page to add ZYME to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
